Indonesian re-IPO

Tempo Scan shareholder to sell up to $140 million of stock

The deal aims to increase the free-float in the Indonesian pharmaceutical and consumer products company from the current 5%. Meanwhile, Global Mediacom is getting ready to spin off its pay-TV unit.

<div style="text-align: left;"> Tempo Scan: treating Indonesia's back pain and other ailments since 1953 </div>

May 08, 2012

The controlling shareholder of Tempo Scan Pacific is aiming to sell between Rp1,250 trillion and Rp1,325 trillion ($133 million to $141 million) of stock in the Indonesian pharmaceutical and consumer products and cosmetics company to help boost the portion of shares held by public investors.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.